Publication | Closed Access

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

InflammationUveitis PatientsMedicineImmunologyActivity DataClinical DermatologySkin PharmacologyDermatologyImmunotherapyPsoriatic ArthritisReceptor Alpha Therapy